Alessandra Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
6,125
+25
+0.4% +$1.44K 0.25% 88
2026
Q1
$370K Buy
+6,100
New +$356K 0.32% 74

Other funds holding BMY

Alessandra Capital Management's BMY Position: Q2 2026 in Review

Alessandra Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.41% in Q2 2026, buying an estimated $1.44K and bringing the position to 6,125 shares worth $353K. The position accounts for 0.25% of the portfolio, ranked #88.

Alessandra Capital Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $370K in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Alessandra Capital Management held 6,125 shares of Bristol-Myers Squibb worth $353K as of Q2 2026.
  • Alessandra Capital Management bought 25 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.44K.
  • Bristol-Myers Squibb made up 0.25% of Alessandra Capital Management's portfolio in Q2 2026, its #88 holding.
  • Alessandra Capital Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • Alessandra Capital Management's Bristol-Myers Squibb position peaked at $370K in Q1 2026.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Alessandra Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.